New CRISPR-based research tool delivers results in an hour in a one-step reaction; Researchers share protocol and kits to advance research and move toward clinical validation.
The diagnostic platform CARMEN combines microfluidics with the CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
A new adenine base editor expands the range of genetic sites that can be edited in human cells, with speed and efficiency far surpassing the original editor.
“Prime editing” combines two key proteins and a new RNA to make targeted insertions, deletions, and all possible single-letter changes in the DNA of human cells